Methods Of Treating Cognitive Impairment

Abstract

The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.


Claims
Owners (US)

Information currently unavailable.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 11, 2017
  • Application: Jun 4, 2015
    US US 201514730485 A
  • Priority: Jun 4, 2015
    US US 201514730485 A
  • Priority: Jun 21, 2011
    US US 201113165344 A
  • Priority: Feb 3, 2011
    US US 201113057387 A
  • Priority: Aug 4, 2009
    US US 2009/0052742 W
  • Priority: Aug 5, 2008
    US US 8635108 P

Download Citation


Sign in to the Lens

Feedback